These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16608112)

  • 1. [Phenotropil in the treatment of vascular encephalopathy].
    Gustov AA; Smirnov AA; Korshunova IuA; Andrianova EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(3):52-3. PubMed ID: 16608112
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of reminyl (galantamine) in the treatment of probable vascular dementia].
    Mokhova OI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(9):77-9. PubMed ID: 19911468
    [No Abstract]   [Full Text] [Related]  

  • 3. [A comparative study of noopept and piracetam in the treatment of mild and moderate cognitive impairment in patients with organic brain diseases of vascular and traumatic origin].
    Neznamov GG; Teleshova ES
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(3):33-42. PubMed ID: 18697252
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic effect of piracetam with nimodipine on vascular dementia after cerebral infarction.
    Zongfang Z; Wenjing L; Zhaomin C; Lei Z
    Pak J Pharm Sci; 2020 Sep; 33(5(Special)):2405-2411. PubMed ID: 33832882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of galantamine in Alzheimer's disease associated with vascular dementia (according to the study of T. Erkinjuntti group)].
    Damulin IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5):65-7. PubMed ID: 19938276
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia].
    Tariska P; Paksy A
    Orv Hetil; 2000 May; 141(22):1189-93. PubMed ID: 10853348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of noopept in discirculatory encephalopathy].
    Barantsevich ER; Posokhina OV; Sturova IuV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5):62-4. PubMed ID: 19938275
    [No Abstract]   [Full Text] [Related]  

  • 8. [Vinpotropile in the treatment of cerebral vascular diseases].
    Filimonov VA; Kliueva VN; Kondrasheva IN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(2):58-60. PubMed ID: 18689000
    [No Abstract]   [Full Text] [Related]  

  • 9. [Piracetam as a corrector of long-term learning disorders caused by prenatal alcohol exposure: the significance of the length of therapy].
    Trofimov SS; Ostrovskaia RU; Smol'nikova NM; Kravchenko EV; Nemova EP; Voronina TA
    Biull Eksp Biol Med; 1996 Apr; 121(4):435-7. PubMed ID: 8829460
    [No Abstract]   [Full Text] [Related]  

  • 10. [Does treatment with piracetam in stroke patients with aphasia make sense?].
    Schmidtke K
    Dtsch Med Wochenschr; 2002 Dec; 127(49):2636. PubMed ID: 12469280
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative studies of Noopept and piracetam in the treatment of patients with mild cognitive disorders in organic brain diseases of vascular and traumatic origin.
    Neznamov GG; Teleshova ES
    Neurosci Behav Physiol; 2009 Mar; 39(3):311-21. PubMed ID: 19234797
    [No Abstract]   [Full Text] [Related]  

  • 12. [The results of using lucetam in patients with moderate cognitive impairment of different genesis].
    Batysheva TT; Otcheskaia OV; Nesterova ON; Lisinker LN; Bobina LA; Ismailov AM; Shekkhirimov RK; Zhuravleva EIu; Kamchatnov PR; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(12):63-5. PubMed ID: 19255983
    [No Abstract]   [Full Text] [Related]  

  • 13. [EEG and clinical psychophysiological study of functional changes in the chronic ischemic brain with increased acetylcholinergic activity].
    Sorokina ND; Selitskiĭ GV; Kositsyn NS
    Fiziol Cheloveka; 2007; 33(3):35-9. PubMed ID: 17619614
    [No Abstract]   [Full Text] [Related]  

  • 14. [Efficacy of prolonged therapy of vascular dementia].
    Klin Med (Mosk); 2011; 89(5):57-60. PubMed ID: 22242270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experience with using high doses of cerebrolysin in vascular dementia].
    Iakhno NN; Damulin IV; Zakharov VV; Levin OS; Elkin MN
    Ter Arkh; 1996; 68(10):65-9. PubMed ID: 9026950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The consequences of closed traumatic brain injury and piracetam efficacy in their treatment in adolescents].
    Zavadenko NN; Guzilova LS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(3):43-8. PubMed ID: 18427539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levetiracetam for manic behavior in hospitalized geriatric patients with dementia of the Alzheimer's type.
    Kyomen HH; Whitfield TH; Baldessarini RJ
    J Clin Psychopharmacol; 2007 Aug; 27(4):408-10. PubMed ID: 17632234
    [No Abstract]   [Full Text] [Related]  

  • 18. [The use of the combined drug vinpotropil at early stages of cerebrovascular insufficiency].
    Zakharov VV; Lokshina AB; Stakhovskaia LV; Timerbaeva SL; Lagoda OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(9):76-8. PubMed ID: 18686371
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of piracetam on urea-induced myoclonus in rats].
    Nanri M; Yamamoto A; Matsuura N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 May; 20(2):45-50. PubMed ID: 11062861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Traditional dementia concepts in transition--must we change our views?].
    Nervenarzt; 2005 Sep; 76(9):2p following 1164. PubMed ID: 16320378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.